Overall costs of radiation therapy for early-stage breast cancer do not burden the health care system when analyzed in relation to survival benefit. READ MORE
The use of digital breast tomosynthesis decreased false positive rates while increasing true negative rates when compared with traditional digital mammography.
Non-Hispanic black patients with localized breast cancer who received neoadjuvant chemotherapy experienced worse distant relapse-free survival outcomes when compared with non-Hispanic white patients.
Elderly patients with untreated early-stage triple-negative breast cancer exhibited a higher mortality rate than patients treated with neoadjuvant or adjuvant therapy.
Women with HER2-positive breast cancer who received sequential trastuzumab did not experience a significant difference in overall survival or relapse-free survival when compared with women who received concurrent therapy.